positive bacteria are relatively ineffective against gram-negative bacteria presumably because of the implied barrier function of the outer membrane. This interpretation has been strengthened by studies demonstrating synergism between outer membrane perturbing agents such as EDTA or polymyxin B and specific antibiotics.
In the case of polymyxin B, it is not totally clear that synergism with other antimicrobials is due to disruption of the outer membrane permeability barrier or to interactions with the inner membrane. In order to resolve this question, polymyxin B was covalently attached to agarose in order to limit interactions with the outer surface of E. coli. These studies demonstrate that immobilized polymyxin B acts synergistically with bacitracin, rifampicin, or lysozyme. It is proposed that synergistic effects exhibited by polymyxin B are due to its interaction with the outer membrane system. The growth minimum inhibitory concentration of free polymyxin B for SC 9251 is 1.2 /cg/ml. Polymyxin B, bacitracin, rifampicin and lysozyme were purchased from Sigma. Affi-gel 10 was purchased from Bio-Rad. E. co/i were grown in synthetic media consisting of 50mM potassium phosphate, 0.12m 1 MgCl2, 1 mM (NH4)2SO4, 20 mm sorbitol and 0.1% casein hydrolysate at pH 7.0. Minimal salts media consisted of 40111m K2HPO4, 20 mm KH2PO4, 0.41 mM MgSO4, 10 mM (NH4)2SO4, 1.7 mM sodium citrate, and 10 mM sorbitol at pH 7.0.
Covalent Attachment of Polymyxin B to Agarose
Polymyxin B was attached to agarose beads using Affi-Gel 1011). Affi-Gel 10 is an agarose derivative containing 10 A long spacer arms terminated by carboxy-N-hydroxy-succinimide activated esters.
Polymyxin B was attached to the agarose through an amide bond between the spacer arm and O-amino groups of diaminobutyric acid residues in polymyxin B. Affi-Gel 10 was added to a 15 molar excess of polymyxin B dissolved in 10 mm NaHCO3, pH 7.2 and allowed to react for 12 hours at 4,C. The beads were then washed on a column with 1 M NaCl, distilled water, then batch washed with 6 M guanidineHCl followed by distilled water again. The polymyxin-agarose was dried by successive dehydrations through ethanol, anhydrose methanol and dioxane. The polymyxin-agarose beads were tested for bleed-off of free polymyxin by the methods previously described11). Free polymyxin was not released in the presence of E. coli.
Determination of Growth Minimum Inhibitory Concentrations
Antimicrobial activities were determined in shaker culture. Prior to innoculation, 0.2 mg/ml polymyxin-agarose was allowed to rehydrate in the media for 2 hours. The flasks were then inoculated with approximately 106 cells/ml, allowed to grow for one hour and the second antibiotic, bacitracin or rifampicin (in methanol solution) was added. The concentrations of methanol used had no effect on the growth of the bacteria. After 24 hours incubation, growth of the cultures was determined by light scattering using a Klett spectrophotometer.
Determination of Spheroplast Formation by Polymyxin-Agarose and Lysozyme A culture of 100 ml E. coli SC 9251 was grown to mid-log phase in nutrient media at 37'C, harvested by centrifugation at 4,000 x g, washed once with minimal salts and resuspended in 20 nil of the same. For spheroplast lysis determination, 1.5 ml of the cell suspension was added either to 8.5 nil distilled water, distilled water containing 1.0 mg/nil rehydrated polymyxin-agarose, or 20 /tg/ml polymyxin B. Lysozyme was added to the appropriate samples and the amount of cell lysis monitored by light scattering using a Klett spectrophotometer.
Spheroplast formation was also detected by the change in morphology of the cells as a result of the above treatments. Photomicrographs were taken of control cells and polymyxin-agarose and lysozyme treated cells suspended in either 20% sucrose or distilled water.
Results
Synergism between Polymyxin-Agarose and Bacitracin or Rifanipicin E. co/i SC 9251 was quite sensitive to free polymyxin B (minimum inhibitory concentration of 1.2 /tg/ml) but relatively insensitive to either bacitracin or rifampicin (Table I ). Bacitracin at concentrations greater than 200 /tg/ml had no effect on the growth of this strain. However, in the presence of 0.2 mg/nil polymyxin-agarose, bacitracin completely inhibited E. coli SC 9251 growth at 25 pg/ml.
Growth curves illustrating synergism between bacitracin and polymyxin-agarose are given in Fig. 1 .
At a concentration of 0.2 mg/ml, polymyxin-agarose caused a two-hour growth lag as previously VOL. XXX NO. 12 THE JOURNAL OF ANTIBIOTICS reported11) but in a 14-hour period bacterial growth was comparable to untreated controls or cultures treated with 200 /sg/ml of bacitracin. As shown in Fig. 1 , the combination of polymyxin-agarose and 20 /tg/ml of bacitracin completely inhibited E. coli growth for at least 14 hours. Thus, the activity of bacitracin was enhanced at least 10 fold in the presence of polymyxin-agarose. Similar results were obtained with rifampicin ( Table 1) . The minimal inhibitory concentration of rifampicin against E. coli SC 9251 was in the range of 100 to 200 ,ug/ml. In the presence of polymyxin-agarose, rifampicin completely inhibited E. coli growth at 5 /cg/ml. Underivatized agarose beads or hydrolyzed Affi-Gel 501 did not show synergism with these antibiotics.
The concentrations of polymyxin-agarose employed in these experiments may seem quite high since free polymyxin shows synergism with various antibiotics at much lower concentrations4,5). However, the polymyxin-agarose beads contained approximately 30 /cg of covalently attached polymyxin per 0.2 mg of polymyxin-agarose. Furthermore, if it is assumed that the bacteria can only interact with the surface of the beads, then only a minor percentage of the polymyxin was available for interaction with the bacteria. It is not possible to make accurate estimates for the amount of polymyxin B accessible on the outer surface of the beads. However, the beads were approximately 100 /tm in diameter and the length of the arm to which polymyxin was attached was 10 A. It can be estimated from these dimensions that no more than 1 % of the bound polymyxin was accessible on the surface. (Fig. 2) . Only the latter two preparations showed a decrease in light scattering when suspended in distilled water. Lysis of bacteria treated with lysozyme and polymyxin-agarose occurred with 10 minutes after transfer into distilled water. The extent of lysis was approximately the same for bacteria treated with free or immobilized polymyxin although the kinetics for lysis were somewhat slower with immobilized polymyxin B. Fig. 2 . Osmotic sensitivity of E. coli SC 9251 treated with lysozyme and polymyxin-agarose. E. coli SC 9251 prepared as described in methods was suspended in distilled water, distilled water plus 1 mg/ml lysozyme, distilled water plus I mg/ml polymyxin-agarose, or distilled water plus 20 /tg/ml polymyxin; 1 mg/ml lysozyme plus 1 mg/ml polymyxin-agarose in distilled water; or I mg/ml lysozyme plus 20 pg/ml polymyxin B in distilled water.
Discussion
It is well documented that polymyxin B binds to and disrupts the structure of outer membranes8,9,12). Therefore, it was not absolutely clear that synergism between polymyxin B and other agents was due to outer membrane structural damage or to indirect effects resulting from interactions with the inner membrane.
In this report, we have observed synergism between polymyxin B covalently attached to agarose and bacitracin, rifampicin, or lysozyme. The minimum inhibitory concentrations of bacitracin or rifampicin for E. coli SC 9251 were normally in excess of 100 /tg/ml. In the presence of immobilized polymyxin, minimum inhibitory concentrations decreased at least ten fold. Synergism between immobilized polymyxin B and lysozyme was also observed. Since the antibiotic was attached to agarose beads by a 10 A spacer arm, contact was necessarily limited to the outer surface of E. coli. These results therefore support the proposal that synergism between polymyxin B and various antibiotics is due to disruption of the outer membrane permeability barrier.
It is interesting to note that free and immobilized polymyxin B share a number of common features.
Both forms of the antibiotic appear to disrupt the outer membrane permeability barrier. In addition, free and immobilized polymyxin B inhibit the respiration of gram-negative bacteria and polymyxin resistant E. coli strains were also resistant to immobilized polymyxin B11. These data, taken collectively, suggest that the primary site of polymyxin action against gram-negative bacteria may actually be at the outer membrane rather than the inner membrane as previously assumed. The results reported in this study clearly support the implied barrier function of outer membranes and illustrate that immobilization of some antibiotics is a powerful tool for studying the structure and function of bacterial membranes.
It should be noted that immobilized penicillin has also been used to study interactions between the antibiotic and the D-alanine carboxypeptidase in bacterial membranes15).
